Eli Lilly says expanded Medicare GLP-1 coverage adds patients
CEO Dave Ricks tells CNBC that about 700,000 new seniors started GLP-1 drugs since Medicare coverage began in July, with roughly seven out of the new patients treated with Lilly's Mounjaro/Zepbound, per the article.
Eli Lilly (LLY, Financials), is gaining an early edge as expanded Medicare coverage brings more seniors into the fast-growing market for GLP-1 obesity treatments.CEO Dave Ricks told CNBC that about 700,000 new seniors have started GLP-1 drugs since coverage began in July, with roughly seven out of…